VI
ABMD

Versor Investments’s Abiomed Inc ABMD Stock Holding History

Versor Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-894
Closed -$321K – 731
2021
Q4 		$321K Buy
+894
New +$302K 0.01% 385
2020
Q1 		– Sell
-2,100
Closed -$358K – 364
2019
Q4 		$358K Buy
+2,100
New +$389K 0.02% 250
2019
Q1 		– Sell
-698
Closed -$227K – 347
2018
Q4 		$227K Buy
+698
New +$242K 0.05% 248

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments's ABMD Position: Q1 2022 in Review

Versor Investments sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 894 shares — an estimated $321K sold.

Versor Investments first reported a position in ABMD in Q4 2018 and held it in 3 quarters. The position peaked at $358K in Q4 2019. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Versor Investments reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Versor Investments sold 894 Abiomed Inc shares in Q1 2022, an estimated $321K.
  • Versor Investments first reported a position in Abiomed Inc in Q4 2018 and held it in 3 quarters.
  • Versor Investments's Abiomed Inc position peaked at $358K in Q4 2019.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Versor Investments's 13F filing for Q1 2022, filed 4 May 2022.